Publications by authors named "Julia Tree"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

782

Total Likes

313

Extended Reach

328,273

Social Features

83
S
SARS-CoV-2 infection enhancement by amphotericin B: implications for disease management.
Dung Nguyen, Stephen M Laidlaw, Xiaofeng Dong, Matthew Wand, Amanda Horton, Julia Tree

J Virol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance.
Sabine Bou-Antoun, Sakib Rokadiya, Diane Ashiru-Oredope, Alicia Demirjian, Emma Sherwood, Julia Tree

J Antimicrob Chemother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab') fragments.
Stephen Findlay-Wilson, Linda Easterbrook, Sandra Smith, Neville Pope, Matthew Aldridge, Julia A Tree

Sci Rep· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab') fragments.
Stephen Findlay-Wilson, Linda Easterbrook, Sandra Smith, Neville Pope, Matthew Aldridge, Julia A Tree

Sci Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2.
Mark Thursz, Fouzia Sadiq, Julia A Tree, Peter Karayiannis, David W C Beasley

J Gen Virol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2.
Mark Thursz, Fouzia Sadiq, Julia A Tree, Peter Karayiannis, David W C Beasley

J Gen Virol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection.
Hannah Goldswain, Xiaofeng Dong, Rebekah Penrice-Randal, Muhannad Alruwaili, Ghada T Shawli, Julia A Tree

Genome Biol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linked Mutations in the Ebola Virus Polymerase Are Associated with Organ Specific Phenotypes.
Xiaofeng Dong, Julia Tree, Logan Banadyga, Shihua He, Wenjun Zhu

Microbiol Spectr· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a cost-effective ovine antibody-based therapy against SARS-CoV-2 infection and contribution of antibodies specific to the spike subunit proteins.
Stephen Findlay-Wilson, Linda Easterbrook, Sandra Smith, Neville Pope, Gareth Humphries, Julia Anne Tree

Antiviral Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of SARS-CoV-2 known and novel subgenomic mRNAs in cell culture, animal model, and clinical samples using LeTRS, a bioinformatic tool to identify unique sequence identifiers.
Xiaofeng Dong, Rebekah Penrice-Randal, Hannah Goldswain, Tessa Prince, Nadine Randle, Julia Tree

Gigascience· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction.
Scott E Guimond, Courtney J Mycroft-West, Neha S Gandhi, Julia A Tree, Thuy T Le

ACS Cent Sci· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2.
Kuan-Ying A Huang, Daming Zhou, Tiong Kit Tan, Charles Chen, Helen M E Duyvesteyn, Julia A Tree

Theranostics· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-Dependent Response to Infection with Ebola Virus in the Ferret Model and Evidence of Viral Evolution in the Eye.
Robert J Watson, Julia Tree, Susan A Fotheringham, Yper Hall, Xiaofeng Dong

J Virol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19.
Jiandong Huo, Halina Mikolajek, Audrey Le Bas, Jordan J Clark, Parul Sharma, Julia A Tree

Nat Commun· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.
Jiandong Huo, Audrey Le Bas, Reinis R Ruza, Helen M E Duyvesteyn, Halina Mikolajek, Julia A Tree

Nat Struct Mol Biol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19.
Francisco J Salguero, Andrew D White, Gillian S Slack, Susan A Fotheringham, Kevin R Bewley, Julia A Tree

Nat Commun· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity.
Kathryn A Ryan, Kevin R Bewley, Susan A Fotheringham, Gillian S Slack, Phillip Brown, Julia A Tree

Nat Commun· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses.
Tiong Kit Tan, Pramila Rijal, Rolle Rahikainen, Anthony H Keeble, Lisa Schimanski, Julia A Tree

Nat Commun· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.
Jiangdong Huo, Audrey Le Bas, Reinis R Ruza, Helen M E Duyvesteyn, Halina Mikolajek, Julia A Tree

Nat Struct Mol Biol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient.
Daming Zhou, Helen M E Duyvesteyn, Cheng-Pin Chen, Chung-Guei Huang, Ting-Hua Chen, Julia A Tree

Nat Struct Mol Biol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.
Jiandong Huo, Audrey Le Bas, Reinis R Ruza, Helen M E Duyvesteyn, Halina Mikolajek, Julia A Tree

Nat Struct Mol Biol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.
Jiandong Huo, Yuguang Zhao, Jingshan Ren, Daming Zhou, Helen M E Duyvesteyn, Julia A Tree

Cell Host Microbe· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction.
Monir Ejemel, Qi Li, Shurong Hou, Zachary A Schiller, Julia A Tree

Nat Commun· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence.
Frank M P van Haren, Clive Page, John G Laffey, Antonio Artigas, Marta Camprubi-Rimblas, Julia Tree

Crit Care· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis